As of 2025-07-05, the EV/EBITDA ratio of Asensus Surgical Inc (ASXC) is -1.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. ASXC's latest enterprise value is 87.93 mil USD. ASXC's TTM EBITDA according to its financial statements is -75.08 mil USD. Dividing these 2 quantities gives us the above ASXC EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 18.1x - 24.7x | 21.4x |
| Forward P/E multiples | 24.5x - 27.9x | 25.0x |
| Fair Price | (6.71) - (6.78) | (6.35) |
| Upside | -2028.8% - -2049.4% | -1925.6% |
| Date | EV/EBITDA |